Thus, the activation of NF-κB in AD may enhance miR-15b expression, which is demonstrated in the current study can in turn negatively regulate NF-κB signaling pathway, BACE1 expression, and Aβ accumulation. This evidence concerns the gene NFKB1 and Alzheimer disease.